Loading clinical trials...
Loading clinical trials...
This retrospective observational study will analyze de-identified clinical data from patients with amyotrophic lateral sclerosis (ALS) collected at multiple centers over 7 years. The primary objective...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Biocells Medical
NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more
NCT07233148 · Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), and more
NCT07187388 · Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS), and more
NCT07202494 · Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and more
NCT04244630 · Amyotrophic Lateral Sclerosis (ALS)
Biocells Medical
Warsaw
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions